Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

Open access

Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) is prevalent among obese people and is considered the hepatic manifestation of metabolic syndrome. However, not all obese individuals develop NAFLD. Our objective was to demonstrate the role of the gut microbiota in NAFLD development using transplantation experiments in mice. Design: Two donor C57BL/6J mice were selected on the basis of their responses to a high-fat diet (HFD). Although both mice displayed similar body weight gain, one mouse, called the ‘responder’, developed hyperglycaemia and had a high plasma concentration of pro-inflammatory cytokines. The other, called a ‘non-responder’, was normoglycaemic and had a lower level of systemic inflammation. Germ-free mice were colonised with intestinal microbiota from either the responder or the non-responder and then fed the same HFD. Results: Mice that received microbiota from different donors developed comparable obesity on the HFD. The responder-receiver (RR) group developed fasting hyperglycaemia and insulinaemia, whereas the non-responder-receiver (NRR) group remained normoglycaemic. In contrast to NRR mice, RR mice developed hepatic macrovesicular steatosis, which was confirmed by a higher liver concentration of triglycerides and increased expression of genes involved in de-novo lipogenesis. Pyrosequencing of the 16S ribosomal RNA genes revealed that RR and NRR mice had distinct gut microbiota including differences at the phylum, genera and species levels. Conclusions: Differences in microbiota composition can determine response to a HFD in mice. These results further demonstrate that the gut microbiota contributes to the development of NAFLD independently of obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2012-303816

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. 10.1096/fj.10-164921 · doi:10.1096/fj.10-164921 · Paper page

Cited by

See all 1,001

Metadata

Authors
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., Perlemuter, G., Cassard-Doulcier, A.-M., & Gérard, P.
Affiliations
  • INRA, UMR1319 Micalis, Jouy-en-Josas, France
  • AgroParisTech (FR)
  • Génétique Animale et Biologie Intégrative (FR)
  • Inserm (FR)
  • Université Paris-Sud (FR)
  • INSERM, U996, IPSIT, Clamart, France
Corresponding author
Gérard, Philippe
Venue
Gut
Publisher
BMJ
Published
2012-11-29
Volume
62
Issue
12
Pages
1787-1794
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W1984916935
Cited by
1,001
References
33
Citations by year
2026: 45 · 2025: 67 · 2024: 75 · 2023: 96 · 2022: 98 · 2021: 111 · 2020: 111 · 2019: 97 · 2018: 74 · 2017: 76 · 2016: 55 · 2015: 42 · 2014: 27 · 2013: 25
FWCI
12.01
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
non-alcoholic fatty liver disease, gut microbiota, high-fat diet, fasting hyperglycemia, insulin resistance, hepatic steatosis, de novo lipogenesis, germ-free mice, obesity, systemic inflammation, inflammatory cytokines, 16S rRNA gene sequencing
MeSH terms
Animals, Blood Glucose, Dietary Fats, Fatty Acids, Volatile, Fatty Liver, Intestines, Liver, Male, Mice, Inbred C57BL, RNA, Bacterial, RNA, Ribosomal, 16S, Triglycerides, Polymerase Chain Reaction, Mice, Microbiota, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. https://app.cochat.ai/papers/10.1136/gutjnl-2012-303816
The paper
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., Perlemuter, G., Cassard-Doulcier, A.-M., & Gérard, P. (2013). Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. https://doi.org/10.1136/gutjnl-2012-303816

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.